Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Febena Pharma is a German pharmaceutical company specializing in the development and distribution of high-quality vitamin and mineral supplements, with a particular focus on Vitamin D3 (cholecalciferol) products. The company provides a range of pharmaceutical-grade formulations, including oral drops and tablets, designed to treat and prevent vitamin deficiencies and related bone health conditions such as osteoporosis and rickets. Febena Pharma operates as a mid-sized enterprise, emphasizing reliable supply chains and adherence to strict European manufacturing standards. Their product portfolio is primarily marketed to healthcare professionals and pharmacies within the DACH region (Germany, Austria, Switzerland).
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Febena Pharma.